Literature DB >> 21985215

Cannabis in sport: anti-doping perspective.

Marilyn A Huestis1, Irene Mazzoni, Olivier Rabin.   

Abstract

Since 2004, when the World Anti-Doping Agency assumed the responsibility for establishing and maintaining the list of prohibited substances and methods in sport (i.e. the Prohibited List), cannabinoids have been prohibited in all sports during competition. The basis for this prohibition can be found in the World Anti-Doping Code, which defines the three criteria used to consider banning a substance. In this context, we discuss the potential of cannabis to enhance sports performance, the risk it poses to the athlete's health and its violation of the spirit of sport. Although these compounds are prohibited in-competition only, we explain why the pharmacokinetics of their main psychoactive compound, Δ(9)-tetrahydrocannabinol, may complicate the results management of adverse analytical findings. Passive inhalation does not appear to be a plausible explanation for a positive test. Although the prohibition of cannabinoids in sports is one of the most controversial issues in anti-doping, in this review we stress the reasons behind this prohibition, with strong emphasis on the evolving knowledge of cannabinoid pharmacology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985215      PMCID: PMC3717337          DOI: 10.2165/11591430-000000000-00000

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  114 in total

1.  Alterations to pre-pulse inhibition (PPI) in chronic cannabis users are secondary to sustained attention deficits.

Authors:  Kirsty Elizabeth Scholes; Mathew Thomas Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2009-10-09       Impact factor: 4.530

Review 2.  Role of cannabinoids in the development of fatty liver (steatosis).

Authors:  Vishnudutt Purohit; Rao Rapaka; David Shurtleff
Journal:  AAPS J       Date:  2010-03-05       Impact factor: 4.009

3.  Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.

Authors:  Eugene W Schwilke; Rod G Gullberg; William D Darwin; C Nora Chiang; Jean Lud Cadet; David A Gorelick; Harrison G Pope; Marilyn A Huestis
Journal:  Addiction       Date:  2010-12-06       Impact factor: 6.526

4.  Cannabis use and non-clinical dimensions of psychosis in university students presenting to primary care.

Authors:  R Skinner; L Conlon; D Gibbons; C McDonald
Journal:  Acta Psychiatr Scand       Date:  2011-01       Impact factor: 6.392

5.  The incidence of drugs in drivers killed in Australian road traffic crashes.

Authors:  Olaf H Drummer; Jim Gerostamoulos; Helen Batziris; Mark Chu; John R M Caplehorn; Michael D Robertson; Philip Swann
Journal:  Forensic Sci Int       Date:  2003-07-08       Impact factor: 2.395

6.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

7.  Illicit substance use and its correlates in first episode psychosis.

Authors:  R Mazzoncini; K Donoghue; J Hart; C Morgan; G A Doody; P Dazzan; P B Jones; K Morgan; R M Murray; P Fearon
Journal:  Acta Psychiatr Scand       Date:  2009-10-13       Impact factor: 6.392

8.  Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Authors:  Frances R Levin; John J Mariani; Daniel J Brooks; Shan Xie; Kathleen A Murray
Journal:  Drug Alcohol Depend       Date:  2009-09-03       Impact factor: 4.492

9.  Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Harrison G Pope; Ronald Herning; Jean L Cadet; Marilyn A Huestis
Journal:  Addiction       Date:  2009-10-05       Impact factor: 6.526

10.  The impact of substance use on brain structure in people at high risk of developing schizophrenia.

Authors:  Killian A Welch; Andrew M McIntosh; Dominic E Job; Heather C Whalley; Thomas W Moorhead; Jeremy Hall; David G C Owens; Stephen M Lawrie; Eve C Johnstone
Journal:  Schizophr Bull       Date:  2010-03-11       Impact factor: 9.306

View more
  13 in total

1.  Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions.

Authors:  Arielle S Gillman; Kent E Hutchison; Angela D Bryan
Journal:  Sports Med       Date:  2015-10       Impact factor: 11.136

Review 2.  The potential role of oral fluid in antidoping testing.

Authors:  Sebastien Anizan; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-10-23       Impact factor: 8.327

Review 3.  Current knowledge on cannabinoids in oral fluid.

Authors:  Dayong Lee; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2013-08-25       Impact factor: 3.345

Review 4.  Youth marijuana use: state of the science for the practicing clinician.

Authors:  Scott E Hadland; Sion K Harris
Journal:  Curr Opin Pediatr       Date:  2014-08       Impact factor: 2.856

5.  Cannabis Use and Sport: A Systematic Review.

Authors:  Shgufta Docter; Moin Khan; Chetan Gohal; Bheeshma Ravi; Mohit Bhandari; Rajiv Gandhi; Timothy Leroux
Journal:  Sports Health       Date:  2020-02-05       Impact factor: 3.843

6.  Questions of fairness and anti-doping in US cycling: The contrasting experiences of professionals and amateurs.

Authors:  April D Henning; Paul Dimeo
Journal:  Drugs (Abingdon Engl)       Date:  2015-04-22

Review 7.  Cannabis and the Health and Performance of the Elite Athlete.

Authors:  Mark A Ware; Dennis Jensen; Amy Barrette; Alan Vernec; Wayne Derman
Journal:  Clin J Sport Med       Date:  2018-09       Impact factor: 3.638

Review 8.  Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.

Authors:  Jules A A C Heuberger; Adam F Cohen
Journal:  Sports Med       Date:  2019-04       Impact factor: 11.136

9.  Why should Cannabis be Considered Doping in Sports?

Authors:  Mateus M Bergamaschi; José Alexandre S Crippa
Journal:  Front Psychiatry       Date:  2013-05-15       Impact factor: 4.157

10.  Illicit Drug Use Among Gym-Goers: a Cross-sectional Study of Gym-Goers in Sweden.

Authors:  Yasmina Molero; Ann-Sofie Bakshi; Johanna Gripenberg
Journal:  Sports Med Open       Date:  2017-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.